Watch to learn what we do at the Center for Health + Technology (CHeT)! https://t.co/eR7HEWGGld

We are excited to welcome Anna Wachter and Joe Townsend to their new respective roles as a Research QA Specialist and Coordinator with the Clinical Materials Services Unit (CMSU)! #newhire

Did you know Parkinson's disease is largely preventable? Two of the world's leading neurologists, @RayDorseyMD and @MichaelOkun, just laid out the evidence, and it changes everything we thought we knew about this disease. 👇

Jamie Adams, MD, CHeT’s Innovation Director, will be the Co-Principal Investigator of a new $2.1 million grant from the The National Institutes of Health (NIH) awarded to BioSensics to develop and validate a multi-modal digital health technology for Huntington’s disease (HD).

Capture more meaningful patient-reported data with the Friedreich’s Ataxia Health Indexes, precision-designed for reliability and FDA regulatory compliance in Friedreich’s ataxia studies. Learn more: https://t.co/BXSAVNFMKw Licensing inquires: HealthIndexes@chet.rochester.edu

Today is International Ataxia Awareness Day. We show our support for individuals and families living with ataxia around the world. Your resilience and advocacy are key to advancing awareness, research, and new possibilities. #AtaxiaAwareness #InternationalAtaxiaAwarenessDay

Our Cognitive Impairment Health Indexes are developed and validated according to regulatory and FDA guidance, and measure how patients and caregivers feel and function in clinical studies. Learn more: https://t.co/hysnPu1Ooo Licensing inquires: HealthIndexes@chet.rochester.edu

The Inclusion Body Myositis Health Index (IBM-HI) is a reliable, FDA-compliant, PRO instrument measuring how patients feel/function in response to treatments in clinical studies. Learn more: https://t.co/2DcgbExt0q Licensing inquires: HealthIndexes@chet.rochester.edu

Yesterday, 9/21, was World Alzheimer’s Day. At CHeT, we’re committed to accelerating progress in brain health, and we thank the Alzheimer’s community for inspiring every step forward. #WorldAlzheimersDay #BrainHealth #AlzheimersAwareness

This coming Sunday 9/21 is World Myositis Day. We stand with the myositis community in raising awareness and reinforcing the need for continued research into causes, treatments, and support. #WorldMyositisDay #MyositisAwareness

We are excited to have Kristin Keyes join CHeT as a Senior Business Administrator! Kristin brings extensive experience in business administration, strategic planning, and project management across healthcare and nonprofit sectors. #newhire

Our Duchenne Muscular Dystrophy Health Indexes are validated to meet regulatory standards and designed to capture how patients feel in response to therapeutic treatment in clinical studies. Learn more: https://t.co/E3GIpGpDMJ Licensing inquires: HealthIndexes@chet.rochester.edu

Study Shows Hormone Combination Improved Strength and Function in FSHD Patients

Our Charcot Marie Tooth Health Index (CMT-HI) is a validated, patient-reported outcome measure designed in alignment with regulatory and FDA guidance. Learn more: https://t.co/jwO5OkzZnn For licensing inquires: HealthIndexes@chet.rochester.edu

This Sunday, 9/7, is World Duchenne Awareness Day. The theme “Family: the Heart of Care,” honors families who support individuals living with Duchenne muscular dystrophy. We thank all those who support and push research forward. #WorldDuchenneAwarenessDay #DuchenneAwareness

Understanding the experiences of people with Spinal Muscular Atrophy is key to meaningful outcomes. Our disease-specific SMA Health Indexes help you measure how patients feel and function. Learn more: https://t.co/NPoCMANjgk Licensing inquires: HealthIndexes@chet.rochester.edu

Spinal Muscular Atrophy (SMA) is a rare genetic disorder affecting the motor nerve cells in the spinal cord, leading to progressive muscle weakness. Thanks to advances in research, and the commitment of the SMA families and advocates, new therapies are changing what’s possible.

How can better measures speed up HD clinical trials? On Help 4 HD Live, Dr. Lori Quinn and Dr. Jamie Adams talk about the MEND-HD study and how tracking subtle changes in gait and movement could help bring therapies to people with HD faster. Listen here:

A few of our "Favorite Things" discussed on Neuroscience Perspectives🎙️ 🎶Neurons, and AI, Thalamus, and Pain. Why things are, Genetics, Toxins, and Brain. So many different answers to find These are all reasons we study the mind🎶 Listen Today👉 https://t.co/pk15ZbLicw

“What truly sets CHeT apart... is the people,” says Becky Gravenstede. We’re hiring an Assistant Director, Quality & Regulatory Compliance to help lead clinical trial quality, GCP adherence, and regulatory compliance. Apply now: https://t.co/2voH1V1iL9

New #URochesterResearch finds “safer” PFAS ⬆️ anxiety-related behaviors & memory deficits in male mice – researchers say this is reminiscent of the neurodevelopmental disorders that are male-biased @URNeuroscience @EJNeuroscience https://t.co/onJLDkhMLE https://t.co/lrabKRDv8i